论文部分内容阅读
日前,2009年召开的第69届ADA年会上,由ADA、欧洲糖尿病研究会(EASD)以及国际糖尿病联盟(IDF)成员组成的专家组发布了国际委员会专家报告,建议将HbA_1c作为诊断糖尿病的方法之一。为此,本文将就HbA_1c作为糖尿病筛查与诊断指标的相关问题作一介绍。一、HbA_1c用于糖尿病筛查与诊断的合理性HbA_1c用于筛查与诊断糖尿病具有优越性。首先,FPG与OGTT均需要被检查者空腹至少8h。如患者于早餐后或下午就诊则无法做出准确诊断,除非存在较严重的高血糖,且症状明显。这一空腹采血的检测要求大大减少了糖尿病的被检出几率。而HbA_1c仅需采集静脉血,
Recently, at the 69th ADA Annual Meeting in 2009, a panel of experts from ADA, the European Association for Diabetes Research (EASD) and the International Diabetes Federation (IDF) released an international panel of experts recommending HbA_1c as a diagnostic tool for diabetes One of the ways. To this end, this article will HbA_1c diabetes screening and diagnostic indicators related to make an introduction. First, the rational use of HbA_1c in screening and diagnosis of diabetes HbA_1c has the superiority of screening and diagnosing diabetes. First of all, FPG and OGTT need to be inspected fasting for at least 8h. If the patient visits after breakfast or afternoon can not make an accurate diagnosis, unless there is more serious hyperglycemia, and symptoms. This fasting blood test requirements greatly reduce the detection rate of diabetes. HbA_1c only need to collect venous blood,